Statement: Radiotherapy is used in all cohorts of the primary trial and the secondary trial.
Primary_evidence: INTERVENTION 1:    Radiotherapy/Supportive Care (A)   Patients receive radiotherapy and healing touch therapy from a healing-touch therapist once a week for the duration of their radiotherapy INTERVENTION 2:    Control ARM (B)   Patients receive radiotherapy and sham healing touch therapy from a sham healing-touch therapist once a week for the duration of their radiotherapy
Secondary_evidence: INTERVENTION 1:    Participants With Stage 0-III Breast Cancer   Women with Stage 0-III breast cancer, treated with breast conserving surgery or mastectomy and clear margins, will receive 15 doses of radiation over three weeks.   Hypofractionated Simultaneous Integrated Boost Radiotherapy: Participants will receive radiotherapy treatments to the whole breast or chest wall to a dose of 2.66 Gy per day x 15 fractions simultaneously with a boost treatment. The boost treatment will be given on the same days as the whole breast treatment. The lumpectomy cavity + scar (in lumpectomy patients) or chest wall scar (mastectomy patients) will receive 0.54 Gy per day x 15 fractions.